RECQ1 downregulated glioblastoma cells are hypersensitive to TMZ treatment. The graphs show the cellular surviving fractions measured at different doses of temozolomide in control and RECQ1-depleted T98G and U-87 cells. Surviving fraction values are the mean ± SEM from three independent experiments.
Mendoza-Maldonado et al. Molecular Cancer 2011 10:83 doi:10.1186/1476-4598-10-83